Menu Investors Analyst Coverage Overview Press Releases Events + Presentations Company Information Stock Information Analyst Coverage SEC Filings Corporate Governance News Alerts Analyst Coverage FirmAnalyst H.C. Wainwright & Co., LLCRaghuram Selvaraju, Ph.D. ThinkEquity, A division of Fordham Financial Management Inc.Ashok Kumar, PhD, CFA Vallon Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Vallon Pharmaceuticals, Inc.’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vallon Pharmaceuticals, Inc. or its management. Vallon Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Sign Up for Updates © 2021 Vallon Pharmaceuticals | Terms of Use | Privacy Policy ADAIR is an investigational new drug product and has not yet been approved by the FDA. All trademarks shown are the property of their respective owners.